Peach, Megan LBeedie, Shaunna-LChau, Cindy H.Collins, Matthew KMarkolovic, SuzanaLuo, WeimingTweedie, DavidSteinebach, ChristianGreig, Nigel HGütschow, MichaelVargesson, NeilNicklaus, Marc C.Figg, William D2020-12-032020-12-032020-12-02Peach, M L, Beedie, S-L, Chau, C H, Collins, M K, Markolovic, S, Luo, W, Tweedie, D, Steinebach, C, Greig, N H, Gütschow, M, Vargesson, N, Nicklaus, M C & Figg, W D 2020, 'Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs', Molecules, vol. 25, no. 23, 5683. https://doi.org/10.3390/molecules252356831420-3049ORCID: /0000-0001-8027-114X/work/145270779https://hdl.handle.net/2164/15442Funding: This research was supported in part by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute (ZIA SC006538); in part with Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E; the Intramural Research Program of the National Institute on Aging, National Institutes of Health; and a Wellcome Trust-NIH PhD Studentship to SB, WDF, and NV (Grant number 098252/Z/12/Z). Acknowledgments: The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.185136494engangiogenesisthalidomideSARcereblondockingstructure-activityrelationshipsstructure–activity relationshipsR MedicineDrug DiscoveryAnalytical ChemistryChemistry (miscellaneous)Molecular MedicinePhysical and Theoretical ChemistryPharmaceutical ScienceOrganic ChemistryWellcome Trust098252/Z/12/ZSupplementary DataRJournal article10.3390/molecules25235683http://www.scopus.com/inward/record.url?scp=85097310887&partnerID=8YFLogxK2523